Insiders · Profile

Kishimoto Takashi Kei

Chief Scientific Officer at Cartesian Therapeutics. Filing since 28 Dec 2016. CIK 0001676930

Company
Date
Role
Action
Shares
Amount
Of holding
5 Jan 2023
Chief Scientific Officer
Sold, plan not stated
3,392
$3.83K
0.9%
4 Jan 2023
Chief Scientific Officer
Sold, plan not stated
6,392
$7.25K
1.7%
5 Jan 2022
Chief Scientific Officer
Sold, plan not stated
3,416
$10.54K
1.3%
10 Dec 2021
Chief Scientific Officer
Sold, plan not stated
4,370
$13.05K
2.1%
13 Oct 2021
Chief Scientific Officer
Sold, plan not stated
3,892
$17.09K
2.0%
28 Dec 2016
Chief Scientific Officer
Sold, plan not stated
10,000
$175.50K
100%
6 decisions on file.